{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:30:45Z","timestamp":1794573045024,"version":"4.9.1"},"reference-count":230,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007311","name":"Cleveland Clinic","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100007311","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Viruses"],"DOI":"10.1038\/s44298-026-00174-9","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:58:26Z","timestamp":1769633906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mechanistic insights into the impact of prenatal viral infections on maternal and offspring immunity"],"prefix":"10.1038","volume":"4","author":[{"given":"Gielenny M.","family":"Salem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamiris","family":"Azamor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora","family":"Familiar-Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chineme","family":"Onwubueke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Catherine","family":"Cambou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Nielsen-Saines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suan-Sin","family":"Foo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"174_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40794-023-00213-w","volume":"10","author":"N Hcini","year":"2024","unstructured":"Hcini, N. et al. Arboviruses and pregnancy: are the threats visible or hidden? Trop. Dis. Travel Med Vaccines 10, 4 (2024).","journal-title":"Trop. Dis. Travel Med Vaccines"},{"key":"174_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ogc.2020.12.001","volume":"48","author":"SC Rogan","year":"2021","unstructured":"Rogan, S. C. & Beigi, R. H. Management of Viral Complications of Pregnancy: Pharmacotherapy to Reduce Vertical Transmission. Obstet. Gynecol. Clin. North Am. 48, 53\u201374 (2021).","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"174_CR3","doi-asserted-by":"publisher","first-page":"10695","DOI":"10.1523\/JNEUROSCI.2178-07.2007","volume":"27","author":"SE Smith","year":"2007","unstructured":"Smith, S. E., Li, J., Garbett, K., Mirnics, K. & Patterson, P. H. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 27, 10695\u201310702 (2007).","journal-title":"J. Neurosci."},{"key":"174_CR4","doi-asserted-by":"publisher","first-page":"7654","DOI":"10.1523\/JNEUROSCI.0091-13.2013","volume":"33","author":"TV Lipina","year":"2013","unstructured":"Lipina, T. V., Zai, C., Hlousek, D., Roder, J. C. & Wong, A. H. Maternal immune activation during gestation interacts with Disc1 point mutation to exacerbate schizophrenia-related behaviors in mice. J. Neurosci. 33, 7654\u20137666 (2013).","journal-title":"J. Neurosci."},{"key":"174_CR5","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1176\/appi.ajp.2018.17121311","volume":"175","author":"AS Brown","year":"2018","unstructured":"Brown, A. S. & Meyer, U. Maternal Immune Activation and Neuropsychiatric Illness: A Translational Research Perspective. Am. J. Psychiatry 175, 1073\u20131083 (2018).","journal-title":"Am. J. Psychiatry"},{"key":"174_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ogc.2023.02.010","volume":"50","author":"AM Dude","year":"2023","unstructured":"Dude, A. M., Jones, M. & Wilson, T. Human Immunodeficiency Virus in Pregnancy. Obstet. Gynecol. Clin. North Am. 50, 389\u2013399 (2023).","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"174_CR7","doi-asserted-by":"publisher","first-page":"166206","DOI":"10.1016\/j.bbadis.2021.166206","volume":"1867","author":"L Cerveny","year":"2021","unstructured":"Cerveny, L., Murthi, P. & Staud, F. HIV in pregnancy: Mother-to-child transmission, pharmacotherapy, and toxicity. Biochim Biophys. Acta Mol. Basis Dis. 1867, 166206 (2021).","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"174_CR8","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1097\/QAD.0000000000002128","volume":"33","author":"S Dirajlal-Fargo","year":"2019","unstructured":"Dirajlal-Fargo, S. et al. HIV-exposed-uninfected infants have increased inflammation and monocyte activation. Aids 33, 845\u2013853 (2019).","journal-title":"Aids"},{"key":"174_CR9","first-page":"122","volume":"41","author":"R Johann-Liang","year":"1997","unstructured":"Johann-Liang, R., Cervia, J. & Noel, G. J. Serum levels of Interleukin-6 (IL-6) and failing to thrive (FTT) in children infected with human immunodeficiency virus (HIV). \u2666 719. Pediatr. Res. 41, 122\u2013122 (1997).","journal-title":"Pediatr. Res."},{"key":"174_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3233\/NPM-200460","volume":"13","author":"TG Elgin","year":"2020","unstructured":"Elgin, T. G. et al. The changing landscape of SARS-CoV-2: Implications for the maternal-infant dyad. J. Neonatal Perinat. Med 13, 293\u2013305 (2020).","journal-title":"J. Neonatal Perinat. Med"},{"key":"174_CR11","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/s41590-021-01049-2","volume":"22","author":"S Gee","year":"2021","unstructured":"Gee, S. et al. The legacy of maternal SARS-CoV-2 infection on the immunology of the neonate. Nat. Immunol. 22, 1490\u20131502 (2021).","journal-title":"Nat. Immunol."},{"key":"174_CR12","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/ppe.12883","volume":"36","author":"EO Olsen","year":"2022","unstructured":"Olsen, E. O. et al. SARS-CoV-2 infections among neonates born to pregnant people with SARS-CoV-2 infection: Maternal, pregnancy and birth characteristics. Paediatr. Perinat. Epidemiol. 36, 476\u2013484 (2022).","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"174_CR13","doi-asserted-by":"publisher","first-page":"E540","DOI":"10.1503\/cmaj.202604","volume":"193","author":"SQ Wei","year":"2021","unstructured":"Wei, S. Q., Bilodeau-Bertrand, M., Liu, S. & Auger, N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ 193, E540\u2013E548 (2021).","journal-title":"CMAJ"},{"key":"174_CR14","doi-asserted-by":"publisher","first-page":"100453","DOI":"10.1016\/j.xcrm.2021.100453","volume":"2","author":"SS Foo","year":"2021","unstructured":"Foo, S. S. et al. The systemic inflammatory landscape of COVID-19 in pregnancy: Extensive serum proteomic profiling of mother-infant dyads with in utero SARS-CoV-2. Cell Rep. Med 2, 100453 (2021).","journal-title":"Cell Rep. Med"},{"key":"174_CR15","doi-asserted-by":"crossref","unstructured":"Grohskopf, L. A., Ferdinands, J. M., Blanton, L. H., Broder, K. R. & Loehr, J. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-25 Influenza Season. 1\u201317 (US Department of Health and Human Services, Centers for Disease Control and Prevention, 2024).","DOI":"10.15585\/mmwr.rr7305a1"},{"key":"174_CR16","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1038\/s41380-025-03059-0","volume":"30","author":"JP Selten","year":"2025","unstructured":"Selten, J. P. & Morgan, V. A. The evidence of influenza A virus infection during pregnancy as a risk factor for neuropsychiatric disorder in offspring. Mol. Psychiatry 30, 3835\u20133836 (2025).","journal-title":"Mol. Psychiatry"},{"key":"174_CR17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/0140-6736(90)90349-A","volume":"335","author":"SH Lewis","year":"1990","unstructured":"Lewis, S. H., Reynolds-Kohler, C., Fox, H. E. & Nelson, J. A. HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in eight-week fetuses. Lancet 335, 565\u2013568 (1990).","journal-title":"Lancet"},{"key":"174_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/QCO.0000000000000267","volume":"29","author":"EL Johnson","year":"2016","unstructured":"Johnson, E. L. & Chakraborty, R. HIV-1 at the placenta: immune correlates of protection and infection. Curr. Opin. Infect. Dis. 29, 248\u2013255 (2016).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"174_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-9-101","volume":"9","author":"EL Johnson","year":"2012","unstructured":"Johnson, E. L. & Chakraborty, R. Placental Hofbauer cells limit HIV-1 replication and potentially offset mother to child transmission (MTCT) by induction of immunoregulatory cytokines. Retrovirology 9, 101 (2012).","journal-title":"Retrovirology"},{"key":"174_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18933-4","volume":"11","author":"C Fenizia","year":"2020","unstructured":"Fenizia, C. et al. Analysis of SARS-CoV-2 vertical transmission during pregnancy. Nat. Commun. 11, 5128 (2020).","journal-title":"Nat. Commun."},{"key":"174_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-53580-5","volume":"14","author":"L Lucot-Royer","year":"2024","unstructured":"Lucot-Royer, L. et al. Analysis of the transplacental transmission of SARS CoV-2 virus and antibody transfer according to the gestational age at maternal infection. Sci. Rep. 14, 3458 (2024).","journal-title":"Sci. Rep."},{"key":"174_CR22","doi-asserted-by":"publisher","first-page":"24964","DOI":"10.1073\/pnas.2006905117","volume":"117","author":"S Liong","year":"2020","unstructured":"Liong, S. et al. Influenza A virus causes maternal and fetal pathology via innate and adaptive vascular inflammation in mice. Proc. Natl. Acad. Sci. USA 117, 24964\u201324973 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"174_CR23","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/19490976.2018.1560768","volume":"10","author":"A Machiavelli","year":"2019","unstructured":"Machiavelli, A., Duarte, R. T. D., Pires, M. M. S., Zarate-Blades, C. R. & Pinto, A. R. The impact of in utero HIV exposure on gut microbiota, inflammation, and microbial translocation. Gut Microbes 10, 599\u2013614 (2019).","journal-title":"Gut Microbes"},{"key":"174_CR24","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1097\/QAD.0000000000003016","volume":"35","author":"P Vyas","year":"2021","unstructured":"Vyas, P. et al. Impact of HIV status on systemic inflammation during pregnancy. AIDS 35, 2259\u20132268 (2021).","journal-title":"AIDS"},{"key":"174_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1590\/S0036-46652014000200008","volume":"56","author":"MF Barral","year":"2014","unstructured":"Barral, M. F. et al. Risk factors of HIV-1 vertical transmission (VT) and the influence of antiretroviral therapy (ART) in pregnancy outcome. Rev. Inst. Med Trop. Sao Paulo 56, 133\u2013138 (2014).","journal-title":"Rev. Inst. Med Trop. Sao Paulo"},{"key":"174_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11904-023-00655-z","volume":"20","author":"L Yang","year":"2023","unstructured":"Yang, L., Cambou, M. C. & Nielsen-Saines, K. The End Is in Sight: Current Strategies for the Elimination of HIV Vertical Transmission. Curr. HIV\/AIDS Rep. 20, 121\u2013130 (2023).","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"174_CR27","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.vaccine.2016.12.012","volume":"35","author":"D Mertz","year":"2017","unstructured":"Mertz, D. et al. Pregnancy as a risk factor for severe outcomes from influenza virus infection: A systematic review and meta-analysis of observational studies. Vaccine 35, 521\u2013528 (2017).","journal-title":"Vaccine"},{"key":"174_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-74704-x","volume":"14","author":"MC Cambou","year":"2024","unstructured":"Cambou, M. C. et al. Time series analysis of comprehensive maternal deaths in Brazil during the COVID-19 pandemic. Sci. Rep. 14, 23960 (2024).","journal-title":"Sci. Rep."},{"key":"174_CR29","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1172\/JCI87490","volume":"127","author":"K Racicot","year":"2017","unstructured":"Racicot, K. & Mor, G. Risks associated with viral infections during pregnancy. J. Clin. Invest 127, 1591\u20131599 (2017).","journal-title":"J. Clin. Invest"},{"key":"174_CR30","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/s41564-017-0016-3","volume":"2","author":"SS Foo","year":"2017","unstructured":"Foo, S. S. et al. Asian Zika virus strains target CD14(+) blood monocytes and induce M2-skewed immunosuppression during pregnancy. Nat. Microbiol 2, 1558\u20131570 (2017).","journal-title":"Nat. Microbiol"},{"key":"174_CR31","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41593-018-0128-y","volume":"21","author":"MD Rudolph","year":"2018","unstructured":"Rudolph, M. D. et al. Maternal IL-6 during pregnancy can be estimated from newborn brain connectivity and predicts future working memory in offspring. Nat. Neurosci. 21, 765\u2013772 (2018).","journal-title":"Nat. Neurosci."},{"key":"174_CR32","doi-asserted-by":"publisher","first-page":"7316456","DOI":"10.1155\/2021\/7316456","volume":"2021","author":"T Lv","year":"2021","unstructured":"Lv, T., Cao, W. & Li, T. HIV-related immune activation and inflammation: current understanding and strategies. J. Immunol. Res. 2021, 7316456 (2021).","journal-title":"J. Immunol. Res."},{"key":"174_CR33","doi-asserted-by":"publisher","first-page":"e0129425","DOI":"10.1371\/journal.pone.0129425","volume":"10","author":"N Ben Haij","year":"2015","unstructured":"Ben Haij, N. et al. HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes\/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-\u03baB Pathway. PLoS One 10, e0129425 (2015).","journal-title":"PLoS One"},{"key":"174_CR34","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/326711a0","volume":"326","author":"G Nabel","year":"1987","unstructured":"Nabel, G. & Baltimore, D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326, 711\u2013713 (1987).","journal-title":"Nature"},{"key":"174_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fimmu.2020.00153","volume":"11","author":"ATH Cocker","year":"2020","unstructured":"Cocker, A. T. H. et al. Pregnancy Gestation Impacts on HIV-1-Specific Granzyme B Response and Central Memory CD4 T Cells. Front Immunol. 11, 153 (2020).","journal-title":"Front Immunol."},{"key":"174_CR36","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1128\/mr.57.1.183-289.1993","volume":"57","author":"JA Levy","year":"1993","unstructured":"Levy, J. A. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev. 57, 183\u2013289 (1993).","journal-title":"Microbiol Rev."},{"key":"174_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/21505594.2019.1697136","volume":"11","author":"S Blanche","year":"2020","unstructured":"Blanche, S. Mini review: Prevention of mother-child transmission of HIV: 25 years of continuous progress toward the eradication of pediatric AIDS? Virulence 11, 14\u201322 (2020).","journal-title":"Virulence"},{"key":"174_CR38","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/oxfordjournals.aje.a117601","volume":"142","author":"C Rouzioux","year":"1995","unstructured":"Rouzioux, C. et al. Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. The HIV Infection in Newborns French Collaborative Study Group. Am. J. Epidemiol. 142, 1330\u20131337 (1995).","journal-title":"Am. J. Epidemiol."},{"key":"174_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/2193-1801-2-7","volume":"2","author":"B Diwan","year":"2013","unstructured":"Diwan, B., Saxena, R. & Tiwari, A. HIV-2 and its role in conglutinated approach towards Acquired Immunodeficiency Syndrome (AIDS) Vaccine Development. Springerplus 2, 7 (2013).","journal-title":"Springerplus"},{"key":"174_CR40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.15585\/mmwr.mm6903a2","volume":"69","author":"AH Peruski","year":"2020","unstructured":"Peruski, A. H. et al. Trends in HIV-2 Diagnoses and Use of the HIV-1\/HIV-2 Differentiation Test - United States, 2010-2017. MMWR Morb. Mortal. Wkly Rep. 69, 63\u201366 (2020).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"174_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ijgo.2014.05.024","volume":"127","author":"E Lathrop","year":"2014","unstructured":"Lathrop, E., Jamieson, D. J. & Danel, I. HIV and maternal mortality. Int J. Gynaecol. Obstet. 127, 213\u2013215 (2014).","journal-title":"Int J. Gynaecol. Obstet."},{"key":"174_CR42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/trstmh\/trab165","volume":"116","author":"E Ter Schiphorst","year":"2022","unstructured":"Ter Schiphorst, E., Hansen, K. C., Holm, M. & Honge, B. L. Mother-to-child HIV-2 transmission: comparison with HIV-1 and evaluation of factors influencing the rate of transmission. A systematic review. Trans. R. Soc. Trop. Med Hyg. 116, 399\u2013408 (2022).","journal-title":"Trans. R. Soc. Trop. Med Hyg."},{"key":"174_CR43","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1097\/QAD.0b013e3283493ed0","volume":"25","author":"MC Marazzi","year":"2011","unstructured":"Marazzi, M. C. et al. Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes. AIDS 25, 1611\u20131618 (2011).","journal-title":"AIDS"},{"key":"174_CR44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/INF.0000000000004562","volume":"44","author":"KG Sundar","year":"2025","unstructured":"Sundar, K. G. et al. Prompt Initiation of Maternal Antiretroviral Therapy After HIV Seroconversion in Pregnancy Effectively Prevents Vertical Transmission and Other Adverse Infant Outcomes. Pediatr. Infect. Dis. J. 44, 40\u201343 (2025).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"174_CR45","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/aogs.14282","volume":"101","author":"S Shinar","year":"2022","unstructured":"Shinar, S. et al. Perinatal outcomes in women living with HIV-1 and receiving antiretroviral therapy-a systematic review and meta-analysis. Acta Obstet. Gynecol. Scand. 101, 168\u2013182 (2022).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"174_CR46","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1468-1293.2008.00520.x","volume":"9","author":"I Grosch-Woerner","year":"2008","unstructured":"Grosch-Woerner, I. et al. Increased rate of prematurity associated with antenatal antiretroviral therapy in a German\/Austrian cohort of HIV-1-infected women. HIV Med 9, 6\u201313 (2008).","journal-title":"HIV Med"},{"key":"174_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89551-3","volume":"11","author":"C Akoto","year":"2021","unstructured":"Akoto, C., Norris, S. A. & Hemelaar, J. Maternal HIV infection is associated with distinct systemic cytokine profiles throughout pregnancy in South African women. Sci. Rep. 11, 10079 (2021).","journal-title":"Sci. Rep."},{"key":"174_CR48","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/tmi.12858","volume":"22","author":"E Kalk","year":"2017","unstructured":"Kalk, E. et al. Placental pathology in HIV infection at term: a comparison with HIV-uninfected women. Trop. Med Int Health 22, 604\u2013613 (2017).","journal-title":"Trop. Med Int Health"},{"key":"174_CR49","doi-asserted-by":"publisher","first-page":"S691","DOI":"10.1093\/infdis\/jiab494","volume":"224","author":"S Maswime","year":"2021","unstructured":"Maswime, S., Pule, C., Mtshali, Z., Chawana, R. & Matjila, M. HIV, Placental Lesions, and Adverse Perinatal Outcomes. J. Infect. Dis. 224, S691\u2013S693 (2021).","journal-title":"J. Infect. Dis."},{"key":"174_CR50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.placenta.2021.09.006","volume":"115","author":"NM Ikumi","year":"2021","unstructured":"Ikumi, N. M., Matjila, M., Gray, C. M., Anumba, D. & Pillay, K. Placental pathology in women with HIV. Placenta 115, 27\u201336 (2021).","journal-title":"Placenta"},{"key":"174_CR51","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ajog.2005.06.081","volume":"194","author":"BH Chi","year":"2006","unstructured":"Chi, B. H. et al. Acute and chronic chorioamnionitis and the risk of perinatal human immunodeficiency virus-1 transmission. Am. J. Obstet. Gynecol. 194, 174\u2013181 (2006).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"174_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11904-024-00688-y","volume":"21","author":"AN Goulding","year":"2024","unstructured":"Goulding, A. N. et al. Antiretroviral Therapy in Pregnancy: A 2023 Review of the Literature. Curr. HIV\/AIDS Rep. 21, 1\u201310 (2024).","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"174_CR53","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1056\/NEJMoa1905230","volume":"381","author":"R Zash","year":"2019","unstructured":"Zash, R. et al. Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana. N. Engl. J. Med 381, 827\u2013840 (2019).","journal-title":"N. Engl. J. Med"},{"key":"174_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1150-3","volume":"16","author":"R Shivakoti","year":"2018","unstructured":"Shivakoti, R. et al. Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control study. BMC Med 16, 161 (2018).","journal-title":"BMC Med"},{"key":"174_CR55","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0165-0378(97)00018-1","volume":"33","author":"Y Mikyas","year":"1997","unstructured":"Mikyas, Y. et al. Immunologic activation during pregnancy: serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women. J. Reprod. Immunol. 33, 157\u2013170 (1997).","journal-title":"J. Reprod. Immunol."},{"key":"174_CR56","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1182\/blood-2010-07-298992","volume":"117","author":"L Kolte","year":"2011","unstructured":"Kolte, L. et al. Dysregulation of CD4+CD25+CD127lowFOXP3+ regulatory T cells in HIV-infected pregnant women. Blood 117, 1861\u20131868 (2011).","journal-title":"Blood"},{"key":"174_CR57","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.clim.2012.10.001","volume":"145","author":"J Hygino","year":"2012","unstructured":"Hygino, J. et al. The impact of pregnancy on the HIV-1-specific T cell function in infected pregnant women. Clin. Immunol. 145, 177\u2013188 (2012).","journal-title":"Clin. Immunol."},{"key":"174_CR58","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1590\/S0074-02762010000500021","volume":"105","author":"AC Lobato","year":"2010","unstructured":"Lobato, A. C. et al. HIV-1 RNA detection in the amniotic fluid of HIV-infected pregnant women. Mem. Inst. Oswaldo Cruz 105, 720\u2013721 (2010).","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"174_CR59","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1089\/aid.2011.0355","volume":"29","author":"A Farzin","year":"2013","unstructured":"Farzin, A., Boyer, P., Ank, B., Nielsen-Saines, K. & Bryson, Y. Amniotic fluid exhibits an innate inhibitory activity against HIV type 1 replication in vitro. AIDS Res Hum. Retroviruses 29, 77\u201383 (2013).","journal-title":"AIDS Res Hum. Retroviruses"},{"key":"174_CR60","unstructured":"Transmission, P. o. T. o. H. D. P. a. P. o. P. Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States. (2025)."},{"key":"174_CR61","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/infdis\/jiac501","volume":"227","author":"S Shiau","year":"2023","unstructured":"Shiau, S. et al. Unique Profile of Inflammation and Immune Activation in Pregnant People With HIV in the United States. J. Infect. Dis. 227, 720\u2013730 (2023).","journal-title":"J. Infect. Dis."},{"key":"174_CR62","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/FM9.0000000000000133","volume":"4","author":"W Yu","year":"2022","unstructured":"Yu, W., Hu, X. & Cao, B. Viral Infections During Pregnancy: The Big Challenge Threatening Maternal and Fetal Health. Matern Fetal Med 4, 72\u201386 (2022).","journal-title":"Matern Fetal Med"},{"key":"174_CR63","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/S0140-6736(02)11921-0","volume":"360","author":"SM Graham","year":"2002","unstructured":"Graham, S. M. Prophylaxis against Pneumocystis carinii pneumonia for HIV-exposed infants in Africa. Lancet 360, 1966\u20131968 (2002).","journal-title":"Lancet"},{"key":"174_CR64","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S2352-4642(19)30007-0","volume":"3","author":"SM le Roux","year":"2019","unstructured":"le Roux, S. M. et al. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study. Lancet Child Adolesc. Health 3, 234\u2013244 (2019).","journal-title":"Lancet Child Adolesc. Health"},{"key":"174_CR65","doi-asserted-by":"publisher","first-page":"e0007224","DOI":"10.1128\/jvi.00072-24","volume":"98","author":"J Nazziwa","year":"2024","unstructured":"Nazziwa, J. et al. Higher HIV-1 evolutionary rate is associated with cytotoxic T lymphocyte escape mutations in infants. J. Virol. 98, e0007224 (2024).","journal-title":"J. Virol."},{"key":"174_CR66","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3389\/fimmu.2016.00310","volume":"7","author":"C Ruck","year":"2016","unstructured":"Ruck, C., Reikie, B. A., Marchant, A., Kollmann, T. R. & Kakkar, F. Linking Susceptibility to Infectious Diseases to Immune System Abnormalities among HIV-Exposed Uninfected Infants. Front Immunol. 7, 310 (2016).","journal-title":"Front Immunol."},{"key":"174_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87368-8","volume":"11","author":"WB Abange","year":"2021","unstructured":"Abange, W. B. et al. Alteration of the gut fecal microbiome in children living with HIV on antiretroviral therapy in Yaounde, Cameroon. Sci. Rep. 11, 7666 (2021).","journal-title":"Sci. Rep."},{"key":"174_CR68","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1213\/ANE.0000000000004845","volume":"131","author":"S Ludwig","year":"2020","unstructured":"Ludwig, S. & Zarbock, A. Coronaviruses and SARS-CoV-2: A Brief Overview. Anesth. Analg. 131, 93\u201396 (2020).","journal-title":"Anesth. Analg."},{"key":"174_CR69","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jamapediatrics.2021.1050","volume":"175","author":"J Villar","year":"2021","unstructured":"Villar, J. et al. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr. 175, 817\u2013826 (2021).","journal-title":"JAMA Pediatr."},{"key":"174_CR70","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1001\/jama.2022.1190","volume":"327","author":"TD Metz","year":"2022","unstructured":"Metz, T. D. et al. Association of SARS-CoV-2 Infection With Serious Maternal Morbidity and Mortality From Obstetric Complications. Jama 327, 748\u2013759 (2022).","journal-title":"Jama"},{"key":"174_CR71","doi-asserted-by":"publisher","first-page":"100760","DOI":"10.1016\/j.ajogmf.2022.100760","volume":"5","author":"B Serrano","year":"2023","unstructured":"Serrano, B. et al. Confirmation of preeclampsia-like syndrome induced by severe COVID-19: an observational study. Am. J. Obstet. Gynecol. MFM 5, 100760 (2023).","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"174_CR72","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.medj.2024.10.010","volume":"5","author":"KM Aagaard","year":"2024","unstructured":"Aagaard, K. M. & Shamshirsaz, A. A. Lingering impact: Maternal SARS-CoV-2 infection during early pregnancy results in fetal situs inversus. Med 5, 1338\u20131339 (2024).","journal-title":"Med"},{"key":"174_CR73","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.matbio.2005.05.005","volume":"24","author":"Y Yokosaki","year":"2005","unstructured":"Yokosaki, Y., Tanaka, K., Higashikawa, F., Yamashita, K. & Eboshida, A. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin. Matrix Biol. 24, 418\u2013427 (2005).","journal-title":"Matrix Biol."},{"key":"174_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09982-x","volume":"24","author":"APF de Montalvao Franca","year":"2024","unstructured":"de Montalvao Franca, A. P. F. et al. Clinical characteristics of pregnant women with COVID-19 and infection outcomes in one of the largest cities in the Brazilian Amazon. BMC Infect. Dis. 24, 1175 (2024).","journal-title":"BMC Infect. Dis."},{"key":"174_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17436-6","volume":"11","author":"AJ Vivanti","year":"2020","unstructured":"Vivanti, A. J. et al. Transplacental transmission of SARS-CoV-2 infection. Nat. Commun. 11, 3572 (2020).","journal-title":"Nat. Commun."},{"key":"174_CR76","first-page":"e2020036","volume":"91","author":"R Mukhra","year":"2020","unstructured":"Mukhra, R., Krishan, K. & Kanchan, T. Possible modes of transmission of Novel coronavirus SARS-CoV-2: a review. Acta Biomed. 91, e2020036 (2020).","journal-title":"Acta Biomed."},{"key":"174_CR77","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1080\/09273948.2020.1799035","volume":"28","author":"S Ocansey","year":"2020","unstructured":"Ocansey, S. et al. Ocular Symptoms of SARS-CoV-2: Indication of Possible Ocular Transmission or Viral Shedding. Ocul. Immunol. Inflamm. 28, 1269\u20131279 (2020).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"174_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s44318-024-00260-9","author":"T Azamor","year":"2024","unstructured":"Azamor, T. et al. Transplacental SARS-CoV-2 protein ORF8 binds to complement C1q to trigger fetal inflammation. EMBO J. https:\/\/doi.org\/10.1038\/s44318-024-00260-9 (2024).","journal-title":"EMBO J."},{"key":"174_CR79","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s41372-020-00874-x","volume":"41","author":"A Barrero-Castillero","year":"2021","unstructured":"Barrero-Castillero, A. et al. COVID-19: neonatal-perinatal perspectives. J. Perinatol. 41, 940\u2013951 (2021).","journal-title":"J. Perinatol."},{"key":"174_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27745-z","volume":"13","author":"V Garcia-Flores","year":"2022","unstructured":"Garcia-Flores, V. et al. Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2. Nat. Commun. 13, 320 (2022).","journal-title":"Nat. Commun."},{"key":"174_CR81","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/s41556-023-01169-x","volume":"25","author":"L Gao","year":"2023","unstructured":"Gao, L. et al. Single-cell analysis reveals transcriptomic and epigenomic impacts on the maternal\u2013fetal interface following SARS-CoV-2 infection. Nat. Cell Biol. 25, 1047\u20131060 (2023).","journal-title":"Nat. Cell Biol."},{"key":"174_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-17542-z","volume":"12","author":"F Crovetto","year":"2022","unstructured":"Crovetto, F. et al. Nasopharyngeal microbiota profiling of pregnant women with SARS-CoV-2 infection. Sci. Rep. 12, 13404 (2022).","journal-title":"Sci. Rep."},{"key":"174_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810306","author":"CJ Juarez-Castelan","year":"2022","unstructured":"Juarez-Castelan, C. J. et al. The Entero-Mammary Pathway and Perinatal Transmission of Gut Microbiota and SARS-CoV-2. Int J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms231810306 (2022).","journal-title":"Int J. Mol. Sci."},{"key":"174_CR84","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-058271","author":"M Benny","year":"2023","unstructured":"Benny, M. et al. Maternal SARS-CoV-2, Placental Changes and Brain Injury in 2 Neonates. Pediatrics https:\/\/doi.org\/10.1542\/peds.2022-058271 (2023).","journal-title":"Pediatrics"},{"key":"174_CR85","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jaci.2020.10.040","volume":"147","author":"C Cervia","year":"2021","unstructured":"Cervia, C. et al. Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19. J. Allergy Clin. Immunol. 147, 545\u2013557 e549 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"174_CR86","doi-asserted-by":"publisher","first-page":"eabi7428","DOI":"10.1126\/scitranslmed.abi7428","volume":"13","author":"EA Bordt","year":"2021","unstructured":"Bordt, E. A. et al. Maternal SARS-CoV-2 infection elicits sexually dimorphic placental immune responses. Sci. Transl. Med 13, eabi7428 (2021).","journal-title":"Sci. Transl. Med"},{"key":"174_CR87","doi-asserted-by":"publisher","first-page":"999136","DOI":"10.3389\/fimmu.2022.999136","volume":"13","author":"R Rubio","year":"2022","unstructured":"Rubio, R. et al. Maternal and neonatal immune response to SARS-CoV-2, IgG transplacental transfer and cytokine profile. Front Immunol. 13, 999136 (2022).","journal-title":"Front Immunol."},{"key":"174_CR88","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.3346\/jkms.2023.38.e120","volume":"38","author":"D Zhang","year":"2023","unstructured":"Zhang, D. et al. Gut Microbiota Dysbiosis Correlates With Long COVID-19 at One-Year After Discharge. J. Korean Med Sci. 38, e120 (2023).","journal-title":"J. Korean Med Sci."},{"key":"174_CR89","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00889-23","author":"V Upadhyay","year":"2023","unstructured":"Upadhyay, V. et al. Mild SARS-CoV-2 infection results in long-lasting microbiota instability. mBio 14, e0088923 https:\/\/doi.org\/10.1128\/mbio.00889-23 (2023).","journal-title":"mBio 14, e0088923"},{"key":"174_CR90","doi-asserted-by":"publisher","first-page":"1569279","DOI":"10.3389\/fmicb.2025.1569279","volume":"16","author":"O Ignatyeva","year":"2025","unstructured":"Ignatyeva, O. et al. The crossover effect of COVID-19 in pregnancy on the infant microbiome. Front Microbiol 16, 1569279 (2025).","journal-title":"Front Microbiol"},{"key":"174_CR91","doi-asserted-by":"publisher","first-page":"e2215787","DOI":"10.1001\/jamanetworkopen.2022.15787","volume":"5","author":"AG Edlow","year":"2022","unstructured":"Edlow, A. G., Castro, V. M., Shook, L. L., Kaimal, A. J. & Perlis, R. H. Neurodevelopmental Outcomes at 1 Year in Infants of Mothers Who Tested Positive for SARS-CoV-2 During Pregnancy. JAMA Netw. Open 5, e2215787 (2022).","journal-title":"JAMA Netw. Open"},{"key":"174_CR92","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/s41390-022-02266-7","volume":"93","author":"JC Jin","year":"2023","unstructured":"Jin, J. C. et al. SARS CoV-2 detected in neonatal stool remote from maternal COVID-19 during pregnancy. Pediatr. Res 93, 1375\u20131382 (2023).","journal-title":"Pediatr. Res"},{"key":"174_CR93","doi-asserted-by":"publisher","first-page":"e069194","DOI":"10.1136\/bmjopen-2022-069194","volume":"13","author":"V Fajardo Martinez","year":"2023","unstructured":"Fajardo Martinez, V. et al. Neuromotor repertoires in infants exposed to maternal COVID-19 during pregnancy: a cohort study. BMJ Open 13, e069194 (2023).","journal-title":"BMJ Open"},{"key":"174_CR94","doi-asserted-by":"publisher","first-page":"e237396","DOI":"10.1001\/jamanetworkopen.2023.7396","volume":"6","author":"MR Firestein","year":"2023","unstructured":"Firestein, M. R. et al. Assessment of Neurodevelopment in Infants With and Without Exposure to Asymptomatic or Mild Maternal SARS-CoV-2 Infection During Pregnancy. JAMA Netw. Open 6, e237396 (2023).","journal-title":"JAMA Netw. Open"},{"key":"174_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44549-5","volume":"15","author":"OM Man","year":"2024","unstructured":"Man, O. M. et al. Respiratory distress in SARS-CoV-2 exposed uninfected neonates followed in the COVID Outcomes in Mother-Infant Pairs (COMP) Study. Nat. Commun. 15, 399 (2024).","journal-title":"Nat. Commun."},{"key":"174_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-61918-2","volume":"14","author":"V Fajardo-Martinez","year":"2024","unstructured":"Fajardo-Martinez, V. et al. Neurodevelopmental delay in children exposed to maternal SARS-CoV-2 in-utero. Sci. Rep. 14, 11851 (2024).","journal-title":"Sci. Rep."},{"key":"174_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/v14051037","author":"FM de Moraes","year":"2022","unstructured":"de Moraes, F. M. et al. SARS-CoV-2 Infection and Possible Neonatal Neurological Outcomes: A Literature Review. Viruses https:\/\/doi.org\/10.3390\/v14051037 (2022).","journal-title":"Viruses"},{"key":"174_CR98","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0140-6736(22)00982-5","volume":"400","author":"TM Uyeki","year":"2022","unstructured":"Uyeki, T. M., Hui, D. S., Zambon, M., Wentworth, D. E. & Monto, A. S. Influenza. Lancet 400, 693\u2013706 (2022).","journal-title":"Lancet"},{"key":"174_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/v14122729","author":"O Oseghale","year":"2022","unstructured":"Oseghale, O. et al. Influenza Virus Infection during Pregnancy as a Trigger of Acute and Chronic Complications. Viruses https:\/\/doi.org\/10.3390\/v14122729 (2022).","journal-title":"Viruses"},{"key":"174_CR100","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ijdevneu.2004.05.005","volume":"23","author":"L Shi","year":"2005","unstructured":"Shi, L., Tu, N. & Patterson, P. H. Maternal influenza infection is likely to alter fetal brain development indirectly: the virus is not detected in the fetus. Int J. Dev. Neurosci. 23, 299\u2013305 (2005).","journal-title":"Int J. Dev. Neurosci."},{"key":"174_CR101","doi-asserted-by":"publisher","first-page":"G230","DOI":"10.1152\/ajpgi.00062.2023","volume":"325","author":"S Liong","year":"2023","unstructured":"Liong, S. et al. Influenza A virus infection during pregnancy causes immunological changes in gut-associated lymphoid tissues of offspring mice. Am. J. Physiol. Gastrointest. Liver Physiol. 325, G230\u2013G238 (2023).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"174_CR102","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41380-024-02648-9","volume":"30","author":"AM Otero","year":"2025","unstructured":"Otero, A. M. et al. Influenza A virus during pregnancy disrupts maternal intestinal immunity and fetal cortical development in a dose- and time-dependent manner. Mol. Psychiatry 30, 13\u201328 (2025).","journal-title":"Mol. Psychiatry"},{"key":"174_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3435-8","volume":"18","author":"I Laake","year":"2018","unstructured":"Laake, I. et al. Risk of pregnancy complications and adverse birth outcomes after maternal A(H1N1)pdm09 influenza: a Norwegian population-based cohort study. BMC Infect. Dis. 18, 525 (2018).","journal-title":"BMC Infect. Dis."},{"key":"174_CR104","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/irv.12714","volume":"14","author":"AMC Rose","year":"2020","unstructured":"Rose, A. M. C. et al. Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccine. Influenza Other Respir. Viruses 14, 302\u2013310 (2020).","journal-title":"Influenza Other Respir. Viruses"},{"key":"174_CR105","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/nm1477","volume":"12","author":"MD de Jong","year":"2006","unstructured":"de Jong, M. D. et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med 12, 1203\u20131207 (2006).","journal-title":"Nat. Med"},{"key":"174_CR106","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fpsyt.2020.00072","volume":"11","author":"AP Kepinska","year":"2020","unstructured":"Kepinska, A. P. et al. Schizophrenia and Influenza at the Centenary of the 1918-1919 Spanish Influenza Pandemic: Mechanisms of Psychosis Risk. Front Psychiatry 11, 72 (2020).","journal-title":"Front Psychiatry"},{"key":"174_CR107","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.biopsych.2009.11.026","volume":"67","author":"SJ Short","year":"2010","unstructured":"Short, S. J. et al. Maternal influenza infection during pregnancy impacts postnatal brain development in the rhesus monkey. Biol. Psychiatry 67, 965\u2013973 (2010).","journal-title":"Biol. Psychiatry"},{"key":"174_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25220-3","volume":"12","author":"H Jacobsen","year":"2021","unstructured":"Jacobsen, H. et al. Offspring born to influenza A virus infected pregnant mice have increased susceptibility to viral and bacterial infections in early life. Nat. Commun. 12, 4957 (2021).","journal-title":"Nat. Commun."},{"key":"174_CR109","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1089\/jwh.2024.0893","volume":"33","author":"SM Olson","year":"2024","unstructured":"Olson, S. M., Dawood, F. S., Grohskopf, L. A. & Ellington, S. Preventing Influenza Virus Infection and Severe Influenza Among Pregnant People and Infants. J. Women\u2019s. Health (Larchmt.) 33, 1591\u20131598 (2024).","journal-title":"J. Women\u2019s. Health (Larchmt.)"},{"key":"174_CR110","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00402-22","volume":"13","author":"X Wu","year":"2022","unstructured":"Wu, X. et al. Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8. mBio 13, e0040222. https:\/\/doi.org\/10.1128\/mbio.00402-22 (2022).","journal-title":"mBio"},{"key":"174_CR111","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/nm1296-1371","volume":"2","author":"A Albini","year":"1996","unstructured":"Albini, A. et al. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1\/KDR receptor on vascular endothelial cells. Nat. Med 2, 1371\u20131375 (1996).","journal-title":"Nat. Med"},{"key":"174_CR112","doi-asserted-by":"publisher","first-page":"985646","DOI":"10.1155\/2012\/985646","volume":"2012","author":"P Palmeira","year":"2012","unstructured":"Palmeira, P., Quinello, C., Silveira-Lessa, A. L., Zago, C. A. & Carneiro-Sampaio, M. IgG placental transfer in healthy and pathological pregnancies. Clin. Dev. Immunol. 2012, 985646 (2012).","journal-title":"Clin. Dev. Immunol."},{"key":"174_CR113","doi-asserted-by":"publisher","first-page":"4528","DOI":"10.1016\/j.celrep.2020.03.016","volume":"30","author":"Y Tang","year":"2020","unstructured":"Tang, Y. et al. Endogenous Retroviral Envelope Syncytin Induces HIV-1 Spreading and Establishes HIV Reservoirs in Placenta. Cell Rep. 30, 4528\u20134539 e4524 (2020).","journal-title":"Cell Rep."},{"key":"174_CR114","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nri.2017.38","volume":"17","author":"JM Kinder","year":"2017","unstructured":"Kinder, J. M., Stelzer, I. A., Arck, P. C. & Way, S. S. Immunological implications of pregnancy-induced microchimerism. Nat. Rev. Immunol. 17, 483\u2013494 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"174_CR115","first-page":"107","volume":"6","author":"F Fazely","year":"1993","unstructured":"Fazely, F. et al. Simian immunodeficiency virus infection via amniotic fluid: a model to study fetal immunopathogenesis and prophylaxis. J. Acquir Immune Defic. Syndr. (1988) 6, 107\u2013114 (1993).","journal-title":"J. Acquir Immune Defic. Syndr. (1988)"},{"key":"174_CR116","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1182\/blood-2012-06-437566","volume":"120","author":"MJ Bunders","year":"2012","unstructured":"Bunders, M. J. et al. Memory CD4(+)CCR5(+) T cells are abundantly present in the gut of newborn infants to facilitate mother-to-child transmission of HIV-1. Blood 120, 4383\u20134390 (2012).","journal-title":"Blood"},{"key":"174_CR117","doi-asserted-by":"publisher","first-page":"e1003776","DOI":"10.1371\/journal.ppat.1003776","volume":"9","author":"S Gupta","year":"2013","unstructured":"Gupta, S. et al. The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells. PLoS Pathog. 9, e1003776 (2013).","journal-title":"PLoS Pathog."},{"key":"174_CR118","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1128\/JVI.75.10.4780-4791.2001","volume":"75","author":"S Lagaye","year":"2001","unstructured":"Lagaye, S. et al. Cell-to-cell contact results in a selective translocation of maternal human immunodeficiency virus type 1 quasispecies across a trophoblastic barrier by both transcytosis and infection. J. Virol. 75, 4780\u20134791 (2001).","journal-title":"J. Virol."},{"key":"174_CR119","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1089\/08892220152741423","volume":"17","author":"E Matala","year":"2001","unstructured":"Matala, E., Hahn, T., Yedavalli, V. R. & Ahmad, N. Biological characterization of HIV type 1 envelope V3 regions from mothers and infants associated with perinatal transmission. AIDS Res Hum. Retroviruses 17, 1725\u20131735 (2001).","journal-title":"AIDS Res Hum. Retroviruses"},{"key":"174_CR120","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.lfs.2010.09.023","volume":"88","author":"N Ahmad","year":"2011","unstructured":"Ahmad, N. Molecular mechanisms of HIV-1 mother-to-child transmission and infection in neonatal target cells. Life Sci. 88, 980\u2013986 (2011).","journal-title":"Life Sci."},{"key":"174_CR121","doi-asserted-by":"publisher","first-page":"e51615","DOI":"10.1002\/eji.202451615","volume":"55","author":"K Peta","year":"2025","unstructured":"Peta, K., Matjila, M. & Ikumi, N. The Complex Role of CD8+ T Cells in Placental HIV Infection. Eur. J. Immunol. 55, e51615 (2025).","journal-title":"Eur. J. Immunol."},{"key":"174_CR122","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.18.1.19385","volume":"18","author":"EL Johnson","year":"2015","unstructured":"Johnson, E. L., Chu, H., Byrareddy, S. N., Spearman, P. & Chakraborty, R. Placental Hofbauer cells assemble and sequester HIV-1 in tetraspanin-positive compartments that are accessible to broadly neutralizing antibodies. J. Int AIDS Soc. 18, 19385 (2015).","journal-title":"J. Int AIDS Soc."},{"key":"174_CR123","doi-asserted-by":"publisher","first-page":"100315","DOI":"10.1016\/j.xcrm.2021.100315","volume":"2","author":"MH Marichannegowda","year":"2021","unstructured":"Marichannegowda, M. H. et al. Different evolutionary pathways of HIV-1 between fetus and mother perinatal transmission pairs indicate unique immune selection in fetuses. Cell Rep. Med 2, 100315 (2021).","journal-title":"Cell Rep. Med"},{"key":"174_CR124","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cyto.2018.11.018","volume":"115","author":"J Lei","year":"2019","unstructured":"Lei, J., Yin, X., Shang, H. & Jiang, Y. IP-10 is highly involved in HIV infection. Cytokine 115, 97\u2013103 (2019).","journal-title":"Cytokine"},{"key":"174_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-61764-2","volume":"14","author":"LM Bebell","year":"2024","unstructured":"Bebell, L. M. et al. Distinct cytokine profiles in late pregnancy in Ugandan people with HIV. Sci. Rep. 14, 10980 (2024).","journal-title":"Sci. Rep."},{"key":"174_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34709-4","volume":"13","author":"DM Santer","year":"2022","unstructured":"Santer, D. M. et al. Interferon-\u03bb treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity. Nat. Commun. 13, 6992 (2022).","journal-title":"Nat. Commun."},{"key":"174_CR127","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-069778","author":"SL Rowe","year":"2025","unstructured":"Rowe, S. L. et al. COVID-19 Vaccination During Pregnancy and Major Structural Birth Defects. Pediatrics https:\/\/doi.org\/10.1542\/peds.2024-069778 (2025).","journal-title":"Pediatrics"},{"key":"174_CR128","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/infdis\/jiac366","volume":"227","author":"MC Cambou","year":"2023","unstructured":"Cambou, M. C. et al. Longitudinal Evaluation of Antibody Persistence in Mother-Infant Dyads After Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Pregnancy. J. Infect. Dis. 227, 236\u2013245 (2023).","journal-title":"J. Infect. Dis."},{"key":"174_CR129","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39989-y","volume":"14","author":"EA Murphy","year":"2023","unstructured":"Murphy, E. A. et al. SARS-CoV-2 vaccination, booster, and infection in pregnant population enhances passive immunity in neonates. Nat. Commun. 14, 4598 (2023).","journal-title":"Nat. Commun."},{"key":"174_CR130","doi-asserted-by":"publisher","first-page":"e1006757","DOI":"10.1371\/journal.ppat.1006757","volume":"13","author":"EQ Littauer","year":"2017","unstructured":"Littauer, E. Q. et al. H1N1 influenza virus infection results in adverse pregnancy outcomes by disrupting tissue-specific hormonal regulation. PLoS Pathog. 13, e1006757 (2017).","journal-title":"PLoS Pathog."},{"key":"174_CR131","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.antiviral.2009.11.009","volume":"87","author":"M Bollati","year":"2010","unstructured":"Bollati, M. et al. Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antivir. Res 87, 125\u2013148 (2010).","journal-title":"Antivir. Res"},{"key":"174_CR132","doi-asserted-by":"publisher","first-page":"7840","DOI":"10.1073\/pnas.89.16.7840","volume":"89","author":"XY Fu","year":"1992","unstructured":"Fu, X. Y., Schindler, C., Improta, T., Aebersold, R. & Darnell, J. E. Jr. The proteins of ISGF-3, the interferon alpha-induced transcriptional activator, define a gene family involved in signal transduction. Proc. Natl. Acad. Sci. USA 89, 7840\u20137843 (1992).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"174_CR133","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/jmcb\/mjab068","volume":"13","author":"K Feng","year":"2021","unstructured":"Feng, K. et al. Interactome profiling reveals interaction of SARS-CoV-2 NSP13 with host factor STAT1 to suppress interferon signaling. J. Mol. Cell Biol. 13, 760\u2013762 (2021).","journal-title":"J. Mol. Cell Biol."},{"key":"174_CR134","doi-asserted-by":"publisher","first-page":"e03857","DOI":"10.1128\/mbio.03857-21","volume":"13","author":"RL Casazza","year":"2022","unstructured":"Casazza, R. L., Philip, D. T. & Lazear, H. M. Interferon Lambda Signals in Maternal Tissues to Exert Protective and Pathogenic Effects in a Gestational Stage-Dependent Manner. mBio 13, e03857\u201303821 (2022).","journal-title":"mBio"},{"key":"174_CR135","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-10-100","volume":"10","author":"JK Mann","year":"2013","unstructured":"Mann, J. K. et al. Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes. Retrovirology 10, 100 (2013).","journal-title":"Retrovirology"},{"key":"174_CR136","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nm0396-338","volume":"2","author":"O Schwartz","year":"1996","unstructured":"Schwartz, O., Marechal, V., Le Gall, S., Lemonnier, F. & Heard, J. M. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med 2, 338\u2013342 (1996).","journal-title":"Nat. Med"},{"key":"174_CR137","doi-asserted-by":"publisher","first-page":"e0026621","DOI":"10.1128\/JVI.00266-21","volume":"95","author":"A Kumar","year":"2021","unstructured":"Kumar, A. et al. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors. J. Virol. 95, e0026621 (2021).","journal-title":"J. Virol."},{"key":"174_CR138","doi-asserted-by":"publisher","first-page":"e06187","DOI":"10.1016\/j.heliyon.2021.e06187","volume":"7","author":"K Shirato","year":"2021","unstructured":"Shirato, K. & Kizaki, T. SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages. Heliyon 7, e06187 (2021).","journal-title":"Heliyon"},{"key":"174_CR139","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.68563","author":"S Khan","year":"2021","unstructured":"Khan, S. et al. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-\u03baB pathway. Elife https:\/\/doi.org\/10.7554\/eLife.68563 (2021).","journal-title":"Elife"},{"key":"174_CR140","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls, A. C. et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell 181, 281\u2013292.e286 (2020).","journal-title":"Cell"},{"key":"174_CR141","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/ni.1861","volume":"11","author":"T Ichinohe","year":"2010","unstructured":"Ichinohe, T., Pang, I. K. & Iwasaki, A. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat. Immunol. 11, 404\u2013410 (2010).","journal-title":"Nat. Immunol."},{"key":"174_CR142","unstructured":"Human Immunodeficiency Viruses and Human T-Cell Lymphotropic Viruses. IARC Monogr. Eval. Carcinog. Risks Hum. 67, 1\u221227 (1996)."},{"key":"174_CR143","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/35085576","volume":"412","author":"PJ Goulder","year":"2001","unstructured":"Goulder, P. J. et al. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 412, 334\u2013338 (2001).","journal-title":"Nature"},{"key":"174_CR144","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1742-4690-3-21","volume":"3","author":"BP Wellensiek","year":"2006","unstructured":"Wellensiek, B. P., Sundaravaradan, V., Ramakrishnan, R. & Ahmad, N. Molecular characterization of the HIV-1 gag nucleocapsid gene associated with vertical transmission. Retrovirology 3, 21 (2006).","journal-title":"Retrovirology"},{"key":"174_CR145","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1172\/JCI81593","volume":"125","author":"SR Permar","year":"2015","unstructured":"Permar, S. R. et al. Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission. J. Clin. Invest 125, 2702\u20132706 (2015).","journal-title":"J. Clin. Invest"},{"key":"174_CR146","doi-asserted-by":"publisher","first-page":"8055","DOI":"10.1073\/pnas.86.20.8055","volume":"86","author":"P Rossi","year":"1989","unstructured":"Rossi, P. et al. Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers. Proc. Natl. Acad. Sci. USA 86, 8055\u20138058 (1989).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"174_CR147","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1182\/blood-2003-03-0833","volume":"102","author":"V Stove","year":"2003","unstructured":"Stove, V. et al. Signaling but not trafficking function of HIV-1 protein Nef is essential for Nef-induced defects in human intrathymic T-cell development. Blood 102, 2925\u20132932 (2003).","journal-title":"Blood"},{"key":"174_CR148","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1600-0854.2011.01286.x","volume":"13","author":"S Debaisieux","year":"2012","unstructured":"Debaisieux, S., Rayne, F., Yezid, H. & Beaumelle, B. The ins and outs of HIV-1 Tat. Traffic 13, 355\u2013363 (2012).","journal-title":"Traffic"},{"key":"174_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/v13081466","author":"N Khan","year":"2021","unstructured":"Khan, N. & Geiger, J. D. Role of Viral Protein U (Vpu) in HIV-1 Infection and Pathogenesis. Viruses https:\/\/doi.org\/10.3390\/v13081466 (2021).","journal-title":"Viruses"},{"key":"174_CR150","doi-asserted-by":"publisher","first-page":"5079","DOI":"10.1007\/s00018-020-03561-4","volume":"77","author":"J Marino","year":"2020","unstructured":"Marino, J. et al. Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND. Cell Mol. Life Sci. 77, 5079\u20135099 (2020).","journal-title":"Cell Mol. Life Sci."},{"key":"174_CR151","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/07853890.2020.1814962","volume":"53","author":"A Borrajo","year":"2021","unstructured":"Borrajo, A., Spuch, C., Penedo, M. A., Olivares, J. M. & Agis-Balboa, R. C. Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis. Ann. Med 53, 43\u201369 (2021).","journal-title":"Ann. Med"},{"key":"174_CR152","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.nbd.2017.04.015","volume":"105","author":"PJ Gaskill","year":"2017","unstructured":"Gaskill, P. J., Miller, D. R., Gamble-George, J., Yano, H. & Khoshbouei, H. HIV, Tat and dopamine transmission. Neurobiol. Dis. 105, 51\u201373 (2017).","journal-title":"Neurobiol. Dis."},{"key":"174_CR153","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3892\/ijmm.2020.4812","volume":"47","author":"SB Cho","year":"2021","unstructured":"Cho, S. B. et al. Tat\u2011aldose reductase prevents dopaminergic neuronal cell death by inhibiting oxidative stress and MAPK activation. Int J. Mol. Med 47, 751\u2013760 (2021).","journal-title":"Int J. Mol. Med"},{"key":"174_CR154","doi-asserted-by":"publisher","DOI":"10.1186\/s12993-015-0083-7","volume":"11","author":"J Dara","year":"2015","unstructured":"Dara, J. et al. Multivariable analysis to determine if HIV-1 Tat dicysteine motif is associated with neurodevelopmental delay in HIV-infected children in Malawi. Behav. Brain Funct. 11, 38 (2015).","journal-title":"Behav. Brain Funct."},{"key":"174_CR155","doi-asserted-by":"publisher","first-page":"112075","DOI":"10.1016\/j.isci.2025.112075","volume":"28","author":"BJ Yadav-Samudrala","year":"2025","unstructured":"Yadav-Samudrala, B. J., Yadav, A. P., Patel, R. P. & Fitting, S. HIV-1 Tat protein alters medial prefrontal cortex neuronal activity and recognition memory. iScience 28, 112075 (2025).","journal-title":"iScience"},{"key":"174_CR156","doi-asserted-by":"publisher","first-page":"93","DOI":"10.14336\/AD.2019.0323","volume":"11","author":"X Zhao","year":"2020","unstructured":"Zhao, X. et al. Long-term HIV-1 Tat Expression in the Brain Led to Neurobehavioral, Pathological, and Epigenetic Changes Reminiscent of Accelerated Aging. Aging Dis. 11, 93\u2013107 (2020).","journal-title":"Aging Dis."},{"key":"174_CR157","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2021785118","author":"TG Flower","year":"2021","unstructured":"Flower, T. G. et al. Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein. Proc. Natl. Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.2021785118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"174_CR158","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41590-021-00937-x","volume":"22","author":"M Zheng","year":"2021","unstructured":"Zheng, M. et al. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat. Immunol. 22, 829\u2013838 (2021).","journal-title":"Nat. Immunol."},{"key":"174_CR159","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3389\/fimmu.2019.01158","volume":"10","author":"M Koutsakos","year":"2019","unstructured":"Koutsakos, M. et al. Downregulation of MHC Class I Expression by Influenza A and B Viruses. Front Immunol. 10, 1158 (2019).","journal-title":"Front Immunol."},{"key":"174_CR160","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.tips.2009.03.002","volume":"30","author":"RM Krug","year":"2009","unstructured":"Krug, R. M. & Aramini, J. M. Emerging antiviral targets for influenza A virus. Trends Pharmacol. Sci. 30, 269\u2013277 (2009).","journal-title":"Trends Pharmacol. Sci."},{"key":"174_CR161","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4161\/chim.17589","volume":"2","author":"L Leveque","year":"2011","unstructured":"Leveque, L. & Khosrotehrani, K. Can maternal microchimeric cells influence the fetal response toward self antigens?Chimerism 2, 71\u201377 (2011).","journal-title":"Chimerism"},{"key":"174_CR162","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/B:VIRU.0000012260.32578.72","volume":"28","author":"Y Becker","year":"2004","unstructured":"Becker, Y. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers\u2014a review and hypothesis. Virus Genes 28, 5\u201318 (2004).","journal-title":"Virus Genes"},{"key":"174_CR163","doi-asserted-by":"publisher","first-page":"108427","DOI":"10.1016\/j.isci.2023.108427","volume":"26","author":"JF Djoba Siawaya","year":"2023","unstructured":"Djoba Siawaya, J. F. & Maloupazoa Siawaya, A. C. HIV-exposed uninfected infants immune defects: From pathogen sensing, oxidative burst to antigens responses. iScience 26, 108427 (2023).","journal-title":"iScience"},{"key":"174_CR164","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/iid3.507","volume":"9","author":"Y Brito-Perez","year":"2021","unstructured":"Brito-Perez, Y. et al. Impaired T helper cell responses in human immunodeficiency virus-exposed uninfected newborns. Immun. Inflamm. Dis. 9, 1541\u20131553 (2021).","journal-title":"Immun. Inflamm. Dis."},{"key":"174_CR165","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40820-x","volume":"14","author":"EK van der Ploeg","year":"2023","unstructured":"van der Ploeg, E. K. et al. Type-2 CD8(+) T-cell formation relies on interleukin-33 and is linked to asthma exacerbations. Nat. Commun. 14, 5137 (2023).","journal-title":"Nat. Commun."},{"key":"174_CR166","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bbi.2020.08.021","volume":"91","author":"T Sevenoaks","year":"2021","unstructured":"Sevenoaks, T. et al. Association of maternal and infant inflammation with neurodevelopment in HIV-exposed uninfected children in a South African birth cohort. Brain Behav. Immun. 91, 65\u201373 (2021).","journal-title":"Brain Behav. Immun."},{"key":"174_CR167","doi-asserted-by":"publisher","first-page":"349ra100","DOI":"10.1126\/scitranslmed.aaf5103","volume":"8","author":"JM Bender","year":"2016","unstructured":"Bender, J. M. et al. Maternal HIV infection influences the microbiome of HIV-uninfected infants. Sci. Transl. Med 8, 349ra100 (2016).","journal-title":"Sci. Transl. Med"},{"key":"174_CR168","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piaf076","author":"CM McGann","year":"2025","unstructured":"McGann, C. M. et al. Effect of maternal HIV status on the early neonatal microbiome. J. Pediatr. Infect. Dis. Soc. https:\/\/doi.org\/10.1093\/jpids\/piaf076 (2025).","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"174_CR169","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12866-022-02747-z","volume":"23","author":"P Chandiwana","year":"2023","unstructured":"Chandiwana, P. et al. Antenatal gut microbiome profiles and effect on pregnancy outcome in HIV infected and HIV uninfected women in a resource limited setting. BMC Microbiol 23, 4 (2023).","journal-title":"BMC Microbiol"},{"key":"174_CR170","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01577-z","volume":"11","author":"HK Leftwich","year":"2023","unstructured":"Leftwich, H. K. et al. The microbiota of pregnant women with SARS-CoV-2 and their infants. Microbiome 11, 141 (2023).","journal-title":"Microbiome"},{"key":"174_CR171","doi-asserted-by":"publisher","first-page":"110544","DOI":"10.1016\/j.vetmic.2025.110544","volume":"306","author":"CA Gaulke","year":"2025","unstructured":"Gaulke, C. A. et al. Maternal vaccination partially protects piglets against influenza A virus associated alteration of the microbiome and hippocampal gene expression. Vet. Microbiol 306, 110544 (2025).","journal-title":"Vet. Microbiol"},{"key":"174_CR172","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3389\/fimmu.2012.00399","volume":"3","author":"JA Slyker","year":"2012","unstructured":"Slyker, J. A. et al. The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life. Front Immunol. 3, 399 (2012).","journal-title":"Front Immunol."},{"key":"174_CR173","doi-asserted-by":"publisher","first-page":"e0122922","DOI":"10.1128\/mbio.01229-22","volume":"13","author":"CL Jackson","year":"2022","unstructured":"Jackson, C. L. et al. Evolution of the Gut Microbiome in HIV-Exposed Uninfected and Unexposed Infants during the First Year of Life. mBio 13, e0122922 (2022).","journal-title":"mBio"},{"key":"174_CR174","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-022-01230-1","volume":"10","author":"S Grant-Beurmann","year":"2022","unstructured":"Grant-Beurmann, S. et al. Dynamics of the infant gut microbiota in the first 18 months of life: the impact of maternal HIV infection and breastfeeding. Microbiome 10, 61 (2022).","journal-title":"Microbiome"},{"key":"174_CR175","doi-asserted-by":"publisher","first-page":"1506203","DOI":"10.3389\/fimmu.2024.1506203","volume":"15","author":"CH Packer","year":"2024","unstructured":"Packer, C. H. et al. Maternal-fetal cytokine profiles in acute SARS-CoV-2 breakthrough infection after COVID-19 vaccination. Front Immunol. 15, 1506203 (2024).","journal-title":"Front Immunol."},{"key":"174_CR176","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/MPG.0b013e318262a718","volume":"55","author":"CC Chen","year":"2012","unstructured":"Chen, C. C., Huang, J. L., Chang, C. J. & Kong, M. S. Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children. J. Pediatr. Gastroenterol. Nutr. 55, 541\u2013547 (2012).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"174_CR177","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41590-021-01123-9","volume":"23","author":"J Chou","year":"2022","unstructured":"Chou, J., Thomas, P. G. & Randolph, A. G. Immunology of SARS-CoV-2 infection in children. Nat. Immunol. 23, 177\u2013185 (2022).","journal-title":"Nat. Immunol."},{"key":"174_CR178","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.abc1669","volume":"369","author":"MM Lamers","year":"2020","unstructured":"Lamers, M. M. et al. SARS-CoV-2 productively infects human gut enterocytes. Science 369, 50\u201354 (2020).","journal-title":"Science"},{"key":"174_CR179","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mib.2020.05.011","volume":"56","author":"KZ Sanidad","year":"2020","unstructured":"Sanidad, K. Z. & Zeng, M. Y. Neonatal gut microbiome and immunity. Curr. Opin. Microbiol 56, 30\u201337 (2020).","journal-title":"Curr. Opin. Microbiol"},{"key":"174_CR180","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/sj.mp.4001046","volume":"7","author":"SH Fatemi","year":"2002","unstructured":"Fatemi, S. H. et al. Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice. Mol. Psychiatry 7, 633\u2013640 (2002).","journal-title":"Mol. Psychiatry"},{"key":"174_CR181","doi-asserted-by":"publisher","first-page":"6741","DOI":"10.1073\/pnas.1906466117","volume":"117","author":"R Marreiros","year":"2020","unstructured":"Marreiros, R. et al. Disruption of cellular proteostasis by H1N1 influenza A virus causes alpha-synuclein aggregation. Proc. Natl. Acad. Sci. USA 117, 6741\u20136751 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"174_CR182","doi-asserted-by":"publisher","first-page":"7048","DOI":"10.1128\/JVI.00417-11","volume":"85","author":"A Spesock","year":"2011","unstructured":"Spesock, A. et al. The virulence of 1997 H5N1 influenza viruses in the mouse model is increased by correcting a defect in their NS1 proteins. J. Virol. 85, 7048\u20137058 (2011).","journal-title":"J. Virol."},{"key":"174_CR183","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1159\/000481848","volume":"43","author":"Y Yan","year":"2017","unstructured":"Yan, Y. et al. NS1 of H7N9 Influenza A Virus Induces NO-Mediated Cellular Senescence in Neuro2a Cells. Cell Physiol. Biochem 43, 1369\u20131380 (2017).","journal-title":"Cell Physiol. Biochem"},{"key":"174_CR184","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.it.2024.01.006","volume":"45","author":"M Bemark","year":"2024","unstructured":"Bemark, M., Pitcher, M. J., Dionisi, C. & Spencer, J. Gut-associated lymphoid tissue: a microbiota-driven hub of B cell immunity. Trends Immunol. 45, 211\u2013223 (2024).","journal-title":"Trends Immunol."},{"key":"174_CR185","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012516","author":"YS Kim","year":"2022","unstructured":"Kim, Y. S. et al. Mulberry Component Kuwanon C Exerts Potent Therapeutic Efficacy In Vitro against COVID-19 by Blocking the SARS-CoV-2 Spike S1 RBD:ACE2 Receptor Interaction. Int J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms232012516 (2022).","journal-title":"Int J. Mol. Sci."},{"key":"174_CR186","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.slasd.2021.10.012","volume":"27","author":"S Mediouni","year":"2022","unstructured":"Mediouni, S. et al. Identification of potent small molecule inhibitors of SARS-CoV-2 entry. SLAS Discov. 27, 8\u201319 (2022).","journal-title":"SLAS Discov."},{"key":"174_CR187","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s41401-021-00735-z","volume":"43","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein. Acta Pharm. Sin. 43, 788\u2013796 (2022).","journal-title":"Acta Pharm. Sin."},{"key":"174_CR188","doi-asserted-by":"publisher","first-page":"27950","DOI":"10.1021\/acsomega.2c01707","volume":"7","author":"AC Puhl","year":"2022","unstructured":"Puhl, A. C. et al. Computational and Experimental Approaches Identify Beta-Blockers as Potential SARS-CoV-2 Spike Inhibitors. ACS Omega 7, 27950\u201327958 (2022).","journal-title":"ACS Omega"},{"key":"174_CR189","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piaf002","author":"CK Cunningham","year":"2025","unstructured":"Cunningham, C. K. et al. Safety, Tolerability, and Pharmacokinetics of Long-Acting Broadly Neutralizing HIV-1 Monoclonal Antibody VRC07-523LS in Newborn Infants Exposed to HIV-1. J. Pediatr. Infect. Dis. Soc. https:\/\/doi.org\/10.1093\/jpids\/piaf002 (2025).","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"174_CR190","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.antiviral.2019.04.006","volume":"167","author":"JH Beigel","year":"2019","unstructured":"Beigel, J. H. et al. Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference. Antivir. Res 167, 45\u201367 (2019).","journal-title":"Antivir. Res"},{"key":"174_CR191","doi-asserted-by":"publisher","first-page":"2406788","DOI":"10.1080\/19420862.2024.2406788","volume":"16","author":"J Zikos","year":"2024","unstructured":"Zikos, J. et al. FcRn-enhancing mutations lead to increased and prolonged levels of the HIV CCR5-blocking monoclonal antibody leronlimab in the fetuses and newborns of pregnant rhesus macaques. MAbs 16, 2406788 (2024).","journal-title":"MAbs"},{"key":"174_CR192","first-page":"CD014945","volume":"6","author":"C Hirsch","year":"2022","unstructured":"Hirsch, C. et al. SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19. Cochrane Database Syst. Rev. 6, CD014945 (2022).","journal-title":"Cochrane Database Syst. Rev."},{"key":"174_CR193","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/INF.0000000000003773","volume":"42","author":"C Rau","year":"2023","unstructured":"Rau, C. et al. Treatment of Infants and Children With SARS-CoV-2 Monoclonal Antibodies: A European Case Series. Pediatr. Infect. Dis. J. 42, 125\u2013129 (2023).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"174_CR194","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-029058","author":"EG Chadwick","year":"2020","unstructured":"Chadwick, E. G. & Ezeanolue, E. E. & Committee On Pediatric, A. Evaluation and Management of the Infant Exposed to HIV in the United States. Pediatrics https:\/\/doi.org\/10.1542\/peds.2020-029058 (2020).","journal-title":"Pediatrics"},{"key":"174_CR195","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26032","volume":"26","author":"M Penazzato","year":"2023","unstructured":"Penazzato, M. et al. Antiretroviral postnatal prophylaxis to prevent HIV vertical transmission: present and future strategies. J. Int AIDS Soc. 26, e26032 (2023).","journal-title":"J. Int AIDS Soc."},{"key":"174_CR196","first-page":"2049","volume":"65","author":"AH Krist","year":"2002","unstructured":"Krist, A. H. & Crawford-Faucher, A. Management of newborns exposed to maternal HIV infection. Am. Fam. Physician 65, 2049\u20132056 (2002).","journal-title":"Am. Fam. Physician"},{"key":"174_CR197","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/INF.0000000000003364","volume":"41","author":"TG Jacobs","year":"2022","unstructured":"Jacobs, T. G., van Aerde, K. J., Colbers, A. & Burger, D. M. Raltegravir-based Postnatal HIV Prophylaxis Therapy in a Neonate After in Utero Dolutegravir Exposure. Pediatr. Infect. Dis. J. 41, 131\u2013132 (2022).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"174_CR198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/infdis\/jiz385","volume":"222","author":"SM Kilapandal Venkatraman","year":"2020","unstructured":"Kilapandal Venkatraman, S. M., Sivanandham, R., Pandrea, I. & Apetrei, C. BCG Vaccination and Mother-to-Infant Transmission of HIV. J. Infect. Dis. 222, 1\u20133 (2020).","journal-title":"J. Infect. Dis."},{"key":"174_CR199","first-page":"262","volume":"4","author":"SS Wang","year":"2021","unstructured":"Wang, S. S., Yan, Y. S. & Ho, K. US FDA-approved therapeutic antibodies with high-concentration formulation: summaries and perspectives. Antib. Ther. 4, 262\u2013272 (2021).","journal-title":"Antib. Ther."},{"key":"174_CR200","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40259-021-00471-0","volume":"35","author":"S Ko","year":"2021","unstructured":"Ko, S., Jo, M. & Jung, S. T. Recent Achievements and Challenges in Prolonging the Serum Half-Lives of Therapeutic IgG Antibodies Through Fc Engineering. BioDrugs 35, 147\u2013157 (2021).","journal-title":"BioDrugs"},{"key":"174_CR201","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1128\/JVI.06359-11","volume":"86","author":"L Diomede","year":"2012","unstructured":"Diomede, L. et al. Passively transmitted gp41 antibodies in babies born from HIV-1 subtype C-seropositive women: correlation between fine specificity and protection. J. Virol. 86, 4129\u20134138 (2012).","journal-title":"J. Virol."},{"key":"174_CR202","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/COH.0000000000000742","volume":"17","author":"SF Awan","year":"2022","unstructured":"Awan, S. F., Happe, M., Hofstetter, A. R. & Gama, L. Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection. Curr. Opin. HIV AIDS 17, 247\u2013257 (2022).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"174_CR203","doi-asserted-by":"publisher","first-page":"eadr8382","DOI":"10.1126\/science.adr8382","volume":"389","author":"JR Willis","year":"2025","unstructured":"Willis, J. R. et al. Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans. Science 389, eadr8382 (2025).","journal-title":"Science"},{"key":"174_CR204","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fcimb.2019.00069","volume":"9","author":"Q Xiao","year":"2019","unstructured":"Xiao, Q., Guo, D. & Chen, S. Application of CRISPR\/Cas9-Based Gene Editing in HIV-1\/AIDS Therapy. Front Cell Infect. Microbiol 9, 69 (2019).","journal-title":"Front Cell Infect. Microbiol"},{"key":"174_CR205","doi-asserted-by":"publisher","first-page":"1590690","DOI":"10.3389\/fimmu.2025.1590690","volume":"16","author":"JW Wang","year":"2025","unstructured":"Wang, J. W., Liu, J. H. & Xun, J. J. CCR5 gene editing and HIV immunotherapy: current understandings, challenges, and future directions. Front Immunol. 16, 1590690 (2025).","journal-title":"Front Immunol."},{"key":"174_CR206","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092227","author":"V Castelli","year":"2021","unstructured":"Castelli, V. et al. Immune Checkpoint Inhibitors in People Living with HIV\/AIDS: Facts and Controversies. Cells https:\/\/doi.org\/10.3390\/cells10092227 (2021).","journal-title":"Cells"},{"key":"174_CR207","doi-asserted-by":"publisher","first-page":"103840","DOI":"10.1016\/j.ebiom.2022.103840","volume":"76","author":"C Gubser","year":"2022","unstructured":"Gubser, C., Chiu, C., Lewin, S. R. & Rasmussen, T. A. Immune checkpoint blockade in HIV. EBioMedicine 76, 103840 (2022).","journal-title":"EBioMedicine"},{"key":"174_CR208","doi-asserted-by":"publisher","first-page":"264","DOI":"10.15585\/mmwr.mm7107e3","volume":"71","author":"NB Halasa","year":"2022","unstructured":"Halasa, N. B. et al. Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19-Associated Hospitalization in Infants Aged <6 Months - 17 States, July 2021-January 2022. MMWR Morb. Mortal. Wkly Rep. 71, 264\u2013270 (2022).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"174_CR209","doi-asserted-by":"publisher","first-page":"109273","DOI":"10.1016\/j.isci.2024.109273","volume":"27","author":"PA Lopez","year":"2024","unstructured":"Lopez, P. A. et al. Placental transfer dynamics and durability of maternal COVID-19 vaccine-induced antibodies in infants. iScience 27, 109273 (2024).","journal-title":"iScience"},{"key":"174_CR210","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2204399","volume":"387","author":"NB Halasa","year":"2022","unstructured":"Halasa, N. B. et al. Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants. N. Engl. J. Med 387, 109\u2013119 (2022).","journal-title":"N. Engl. J. Med"},{"key":"174_CR211","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-025-01162-5","author":"V Male","year":"2025","unstructured":"Male, V. & Jones, C. E. Vaccination in pregnancy to protect the newborn. Nat. Rev. Immunol. https:\/\/doi.org\/10.1038\/s41577-025-01162-5 (2025).","journal-title":"Nat. Rev. Immunol."},{"key":"174_CR212","doi-asserted-by":"publisher","first-page":"e1011109","DOI":"10.1371\/journal.pcbi.1011109","volume":"19","author":"RE Wessel","year":"2023","unstructured":"Wessel, R. E. & Dolatshahi, S. Quantitative mechanistic model reveals key determinants of placental IgG transfer and informs prenatal immunization strategies. PLoS Comput Biol. 19, e1011109 (2023).","journal-title":"PLoS Comput Biol."},{"key":"174_CR213","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.arcmed.2022.03.001","volume":"53","author":"H Garcia","year":"2022","unstructured":"Garcia, H., Allende-Lopez, A., Morales-Ruiz, P., Miranda-Novales, G. & Villasis-Keever, M. A. COVID-19 in Neonates with Positive RT-PCR Test. Systematic Review. Arch. Med Res 53, 252\u2013262 (2022).","journal-title":"Arch. Med Res"},{"key":"174_CR214","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/s41587-020-0659-0","volume":"38","author":"JD Whitman","year":"2020","unstructured":"Whitman, J. D. et al. Evaluation of SARS-CoV-2 serology assays reveals a range of test performance. Nat. Biotechnol. 38, 1174\u20131183 (2020).","journal-title":"Nat. Biotechnol."},{"key":"174_CR215","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s41372-020-0695-0","volume":"40","author":"S Amatya","year":"2020","unstructured":"Amatya, S. et al. Management of newborns exposed to mothers with confirmed or suspected COVID-19. J. Perinatol. 40, 987\u2013996 (2020).","journal-title":"J. Perinatol."},{"key":"174_CR216","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11020344","author":"E Conte","year":"2023","unstructured":"Conte, E. et al. Do Anti-SARS-CoV-2 Monoclonal Antibodies Have an Impact on Pregnancy Outcome? A Systematic Review and Meta-Analysis. Vaccines (Basel) https:\/\/doi.org\/10.3390\/vaccines11020344 (2023).","journal-title":"Vaccines (Basel)"},{"key":"174_CR217","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41591-021-01643-9","volume":"28","author":"FL van de Veerdonk","year":"2022","unstructured":"van de Veerdonk, F. L. et al. A guide to immunotherapy for COVID-19. Nat. Med 28, 39\u201350 (2022).","journal-title":"Nat. Med"},{"key":"174_CR218","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41392-022-01249-8","volume":"7","author":"S Lei","year":"2022","unstructured":"Lei, S., Chen, X., Wu, J., Duan, X. & Men, K. Small molecules in the treatment of COVID-19. Signal Transduct. Target Ther. 7, 387 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"174_CR219","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.pcl.2014.11.010","volume":"62","author":"RP Santos","year":"2015","unstructured":"Santos, R. P. & Tristram, D. A practical guide to the diagnosis, treatment, and prevention of neonatal infections. Pediatr. Clin. North Am. 62, 491\u2013508 (2015).","journal-title":"Pediatr. Clin. North Am."},{"key":"174_CR220","doi-asserted-by":"publisher","first-page":"568651","DOI":"10.3389\/fimmu.2020.568651","volume":"11","author":"MA Alexander-Miller","year":"2020","unstructured":"Alexander-Miller, M. A. Challenges for the Newborn Following Influenza Virus Infection and Prospects for an Effective Vaccine. Front Immunol. 11, 568651 (2020).","journal-title":"Front Immunol."},{"key":"174_CR221","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1016\/j.vaccine.2020.03.039","volume":"38","author":"TA Suragh","year":"2020","unstructured":"Suragh, T. A., Hibbs, B., Marquez, P. & McNeil, M. M. Age inappropriate influenza vaccination in infants less than 6 months old, 2010-2018. Vaccine 38, 3747\u20133751 (2020).","journal-title":"Vaccine"},{"key":"174_CR222","doi-asserted-by":"publisher","first-page":"5162","DOI":"10.1016\/j.vaccine.2021.07.037","volume":"39","author":"IG Sakala","year":"2021","unstructured":"Sakala, I. G., Honda-Okubo, Y., Li, L., Baldwin, J. & Petrovsky, N. A M2 protein-based universal influenza vaccine containing Advax-SM adjuvant provides newborn protection via maternal or neonatal immunization. Vaccine 39, 5162\u20135172 (2021).","journal-title":"Vaccine"},{"key":"174_CR223","doi-asserted-by":"publisher","first-page":"2486390","DOI":"10.1080\/19420862.2025.2486390","volume":"17","author":"V Verma","year":"2025","unstructured":"Verma, V., Sinha, N. & Raja, A. Nanoscale warriors against viral invaders: a comprehensive review of Nanobodies as potential antiviral therapeutics. MAbs 17, 2486390 (2025).","journal-title":"MAbs"},{"key":"174_CR224","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00018-025-05611-1","volume":"82","author":"A Bonomini","year":"2025","unstructured":"Bonomini, A., Mercorelli, B. & Loregian, A. Antiviral strategies against influenza virus: an update on approved and innovative therapeutic approaches. Cell Mol. Life Sci. 82, 75 (2025).","journal-title":"Cell Mol. Life Sci."},{"key":"174_CR225","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.it.2022.01.007","volume":"43","author":"H-K Kwon","year":"2022","unstructured":"Kwon, H.-K., Choi, G. B. & Huh, J. R. Maternal inflammation and its ramifications on fetal neurodevelopment. Trends Immunol. 43, 230\u2013244 (2022).","journal-title":"Trends Immunol."},{"key":"174_CR226","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1126\/science.aad0314","volume":"351","author":"GB Choi","year":"2016","unstructured":"Choi, G. B. et al. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science 351, 933\u2013939 (2016).","journal-title":"Science"},{"key":"174_CR227","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3389\/fimmu.2020.01023","volume":"11","author":"N Huang","year":"2020","unstructured":"Huang, N., Chi, H. & Qiao, J. Role of Regulatory T Cells in Regulating Fetal-Maternal Immune Tolerance in Healthy Pregnancies and Reproductive Diseases. Front Immunol. 11, 1023 (2020).","journal-title":"Front Immunol."},{"key":"174_CR228","doi-asserted-by":"publisher","first-page":"ltad007","DOI":"10.1093\/immadv\/ltad007","volume":"3","author":"S Sakaguchi","year":"2023","unstructured":"Sakaguchi, S., Kawakami, R. & Mikami, N. Treg-based immunotherapy for antigen-specific immune suppression and stable tolerance induction: a perspective. Immunother. Adv. 3, ltad007 (2023).","journal-title":"Immunother. Adv."},{"key":"174_CR229","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0889-8545(03)00089-5","volume":"30","author":"DM Money","year":"2003","unstructured":"Money, D. M. Antiviral and antiretroviral use in pregnancy. Obstet. Gynecol. Clin. North Am. 30, 731\u2013749 (2003). vii.","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"174_CR230","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.jiph.2020.07.004","volume":"13","author":"D Wang","year":"2020","unstructured":"Wang, D., Li, Z. & Liu, Y. An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics. J. Infect. Public Health 13, 1405\u20131414 (2020).","journal-title":"J. Infect. Public Health"}],"container-title":["npj Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00174-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00174-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00174-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T09:02:07Z","timestamp":1769677327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00174-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":230,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["174"],"URL":"https:\/\/doi.org\/10.1038\/s44298-026-00174-9","relation":{},"ISSN":["2948-1767"],"issn-type":[{"value":"2948-1767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}